These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18047916)

  • 1. Changes in self-monitored pulse pressure correlate with improvements in B-type natriuretic Peptide and urinary albumin in treated hypertensive patients.
    Eguchi K; Matsui Y; Shibasaki S; Ishikawa J; Hoshide S; Ishikawa S; Kabutoya T; Schwartz JE; Pickering TG; Shimada K; Kario K;
    Am J Hypertens; 2007 Dec; 20(12):1268-75. PubMed ID: 18047916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of strict blood pressure control by a long-acting calcium channel blocker on brain natriuretic peptide and urinary albumin excretion rate in Japanese hypertensive patients.
    Uno H; Ishikawa J; Hoshide S; Kabutoya T; Ishikawa S; Shimada K; Kario K
    Hypertens Res; 2008 May; 31(5):887-96. PubMed ID: 18712044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthostatic hypertension detected by self-measured home blood pressure monitoring: a new cardiovascular risk factor for elderly hypertensives.
    Hoshide S; Matsui Y; Shibasaki S; Eguchi K; Ishikawa J; Ishikawa S; Kabutoya T; Schwartz JE; Pickering TG; Shimada K; Kario K;
    Hypertens Res; 2008 Aug; 31(8):1509-16. PubMed ID: 18971524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of the central pulse pressure is useful for detecting cardiac overload during antiadrenergic treatment: the Japan Morning Surge 1 study.
    Matsui Y; Eguchi K; Shibasaki S; Ishikawa J; Hoshide S; Pickering TG; Shimada K; Kario K;
    J Hypertens; 2008 Oct; 26(10):1928-34. PubMed ID: 18806616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of home and ambulatory blood pressure changes with changes in cardiovascular biomarkers during antihypertensive treatment.
    Yano Y; Hoshide S; Shimizu M; Eguchi K; Ishikawa J; Ishikawa S; Shimada K; Kario K
    Am J Hypertens; 2012 Mar; 25(3):306-12. PubMed ID: 22170010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-specific impact of self-monitored pulse pressure on hypertensive target organ damage in treated hypertensive patients.
    Eguchi K; Matsui Y; Shibasaki S; Ishikawa J; Hoshide S; Ishikawa S; Kabutoya T; Schwartz JE; Pickering TG; Shimada K; Kario K;
    J Clin Hypertens (Greenwich); 2007 Jul; 9(7):522-9. PubMed ID: 17617762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase Trend in Home Blood Pressure on a Single Occasion Is Associated With B-Type Natriuretic Peptide and the Estimated Glomerular Filtration Rate.
    Shibasaki S; Hoshide S; Eguchi K; Ishikawa J; Kario K;
    Am J Hypertens; 2015 Sep; 28(9):1098-105. PubMed ID: 25631382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of Central Blood Pressure to Hypertensive Target Organ Damages During Antihypertensive Treatment: The J-TOP Study.
    Shimizu M; Hoshide S; Ishikawa J; Yano Y; Eguchi K; Kario K
    Am J Hypertens; 2015 Aug; 28(8):980-6. PubMed ID: 25548141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between asleep blood pressure and brain natriuretic peptide during antihypertensive treatment: the Japan Morning Surge-Target Organ Protection (J-TOP) study.
    Shimizu M; Ishikawa J; Yano Y; Hoshide S; Eguchi K; Ishikawa S; Shimada K; Kario K
    J Hypertens; 2012 May; 30(5):1015-21. PubMed ID: 22406464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nighttime home blood pressure and the risk of hypertensive target organ damage.
    Ishikawa J; Hoshide S; Eguchi K; Ishikawa S; Shimada K; Kario K;
    Hypertension; 2012 Oct; 60(4):921-8. PubMed ID: 22892810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central pulse pressure links microalbuminuria with plasma B-type natriuretic peptide elevation: causal implication for cardiorenal syndrome in hypertension.
    Hashimoto J; Ito S
    J Hypertens; 2014 Aug; 32(8):1665-71; discussion 1671. PubMed ID: 24906172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Japan Morning Surge-1 (JMS-1) study: protocol description.
    Ishikawa J; Hoshide S; Shibasaki S; Matsui Y; Kabutoya T; Eguchi K; Ishikawa S; Pickering TG; Shimada K; Kario K;
    Hypertens Res; 2006 Mar; 29(3):153-9. PubMed ID: 16755150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulse pressure and subclinical cardiovascular damage in primary hypertension.
    Viazzi F; Leoncini G; Parodi D; Ravera M; Ratto E; Vettoretti S; Tomolillo C; Sette MD; Bezante GP; Deferrari G; Pontremoli R
    Nephrol Dial Transplant; 2002 Oct; 17(10):1779-85. PubMed ID: 12270984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of morning and evening blood pressure at home with asymptomatic organ damage in the J-HOP Study.
    Hoshide S; Kario K; Yano Y; Haimoto H; Yamagiwa K; Uchiba K; Nagasaka S; Matsui Y; Nakamura A; Fukutomi M; Eguchi K; Ishikawa J;
    Am J Hypertens; 2014 Jul; 27(7):939-47. PubMed ID: 24473255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population.
    Fujiwara T; Yano Y; Hoshide S; Kanegae H; Kario K
    JAMA Cardiol; 2018 Jul; 3(7):583-590. PubMed ID: 29800067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New Proposal for the Target Value for Home BP in Type 2 Diabetes Patients: The J-HOP Study.
    Eguchi K; Hoshide S; Komori T; Nagasaka S; Kario K
    Am J Hypertens; 2015 Aug; 28(8):971-9. PubMed ID: 25528450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between B-type natriuretic peptide and within-visit blood pressure variability.
    Rodrigues AB; Gismondi RA; Lagoeiro A; Cecilio AM; Vasques D; Arita R; Folegatti T; Rosa ML
    Clin Cardiol; 2018 Jun; 41(6):778-781. PubMed ID: 29604077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma brain natriuretic peptide: a biochemical marker of effective blood pressure management?
    Andreadis EA; Georgiopoulos DX; Tzavara CK; Katsanou PM; Fragouli EG; Mavrokefalou EM; Chatzis NA; Ifanti GK; Diamantopoulos EJ
    J Hypertens; 2009 Feb; 27(2):425-32. PubMed ID: 19155794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A trial of telmisartan prevention of cardiovascular diseases (ATTEMPT-CVD): Biomarker study.
    Ogawa H; Soejima H; Matsui K; Kim-Mitsuyama S; Yasuda O; Node K; Yamamuro M; Yamamoto E; Kataoka K; Jinnouchi H; Sekigami T;
    Eur J Prev Cardiol; 2016 Jun; 23(9):913-21. PubMed ID: 26324672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An alpha-adrenergic blocker titrated by self-measured blood pressure recordings lowered blood pressure and microalbuminuria in patients with morning hypertension: the Japan Morning Surge-1 Study.
    Kario K; Matsui Y; Shibasaki S; Eguchi K; Ishikawa J; Hoshide S; Ishikawa S; Kabutoya T; Schwartz JE; Pickering TG; Shimada K;
    J Hypertens; 2008 Jun; 26(6):1257-65. PubMed ID: 18475166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.